Earlier stage at diagnosis and improved survival among medicare HMO patients with breast cancer

Journal of Women's Health

Volumn 19, Issue 9, 2010, Pages 1619-1624

  Kirsner, Robert S ^a   Ma, Fangchao ^a   Fleming, Lora E ^a   Federman, Daniel G ^b,c   Trapido, Edward ^a   Duncan, Robert ^a   Rouhani, Panta ^a   Wilkinson, James D ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; EARLY CANCER; FEMALE; HEALTH CARE DELIVERY; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAID; MEDICARE; NATIONAL HEALTH ORGANIZATION; PRIORITY JOURNAL; SURVIVAL RATE;

BREAST NEOPLASMS; EARLY DIAGNOSIS; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; KAPLAN-MEIER ESTIMATE; MEDICARE; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; SEER PROGRAM; UNITED STATES;

EID: 77956370882     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1768     Document Type: Article

References (34)

1. Dutt HR. Developing Medicare HMO market areas and their implications for HMO capitation rates. Managed Care Interface 2003;16:20-25.
2. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care 2002;40(Suppl 4):3-18.
3. Federman DG, Kirsner RS. The abilities of primary care physicians in dermatology: Implications for quality of care. Am J Managed Care 1997;3:1487-1492.
4. Potosky AL, Merrill GM, Riley GF, et al. Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patients. Health Serv Res 1999;34:525-546.
5. Delaet DE, Shea S, Carrasquillo O. Receipt of preventative services among privately insured minorities in managed care versus fee-for-service insurance plans. J Gen Intern Med 2002;17:451-457.
6. Riley GF, Potosky AL, Lubitz JD, Brown ML. Stage of cancer at diagnosis for Medicare HMO and fee-for-service en-rollees. Am J Public Health 1994;84:1598-1604.
7. Potosky AL, Breen N, Graubard BI, Parsons PE. The association between health care coverage and the use of cancer screening tests. Results from the 1992 National Health Interview Survey. Med Care 1998;36:257-270.
8. Bernstein AB, Thompson GB, Harlan LC. Differences in rates of cancer screening by usual source of medical care. Data from the 1987 National Health Interview Survey. Med Care 1991;29:196-209.
9. Riley GF, Potosky AL, Klabunde CN, Warren JL, Ballard-Barbash R. Stage at diagnosis and treatment patterns among older women with breast cancer: An HMO and fee-for-service comparison. JAMA 1999;281:720-726.
10. Kirsner RS, Ma F, Fleming L, et al. The effect of Medicare health care systems on women with breast and cervical cancer. Obstet Gynecol 2005;105:1381-1388.
11. Kirsner RS, Wilkinson JD, Ma F, Pacheco H, Federman DG. The association of Medicare health care delivery systems with stage at diagnosis and survival for patients with melanoma. Arch Dermatol 2005;141:753-757.
12. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249.
13. Fentiman IS. Fixed and modifiable risk factors for breast cancer. Int J Clin Pract 2001;55:527-530.
14. Brewster A, Helzlsouer K. Breast cancer epidemiology, prevention, and early detection. Curr Opin Oncol 2001;13: 420-425.
15. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:1784-1792.
16. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;151:716-726.
17. Truog RD. Screening mammography and the "R" word. N Engl J Med 2009;361:2501-2502.
18. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov ), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Available at seer.cancer.gov
19. Ries L, Melbert D, Krapcho M, et al. SEER cancer statistics review, 1975-2004. Bethesda, MD: National Cancer Institute. Available at seer.cancer.gov/csr/1975-2004/
20. Jean-Baptiste R, Gebhard IK. Series IV: Cancer case ascertainment. procedure guidelines for cancer registries. Springfield, IL: North American Association of Central Cancer Registries, 2002.
21. Merrill RM, Dearden KA. How representative are the Surveillance, Epidemiology, and End Results (SEER) program cancer data of the United States? Cancer Causes Control 2004;15:1027-1034.
22. Nattinger AB, McAuliffe TL, Schapira MM. Generalizability of the Surveillance, Epidemiology, and End Results registry population: Factors relevant to epidemiologic and health care research. J Clin Epidemiol 1997;50:939-945.
23. Howe HL, Wu X, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 2006;107:1711-1742.
24. Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005;97:1407-1427.
25. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 2003;95:1276-1299.
26. Gornick ME, Warren JL, Eggers PW, et al. Thirty years of Medicare: Impact on the covered population. Health Care Finance Rev 1996;18:179-237.
27. Potosky AL, Riley GF, Lubitz JD, et al. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 1993;31:732-748.
28. Steenland K. Henley J, Calle E, Thun M. Individual-and area-level socioeconomic status variables as predictors of mortality in a cohort of 179,383 persons. Am J Epidemiol 2004:159:1047-1056.
29. Potosky AL, Merrill RM, Riley GF, et al. Breast cancer survival and treatment in health maintenance organizations and fee-for-service settings. J Natl Cancer Inst 1997;89:1683-1691.
30. Roetzheim RG, Gonzalez EC, Ferrante JM, Pal N, Van Durme DJ, Krison JP. Effects of health insurance and race outcomes on breast outcomes. Cancer 2000;89:2202-2213.
31. Andrulis DP. Access to care is the centerpiece in the elimination of socioeconomic disparities in health. Ann Intern Med 1998;129:412-416.
32. Collins KS, Hall A, Neuhas C. U.S. minorities health: A chartbook. New York: The Commonwealth Fund, 1999.
33. Keating NL, Landrum MB, Meara E, et al. Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector? J Natl Cancer Inst 2005;97:257-264.
34. Khan MM, Tsai WC, Kung PT. Biased enrollment of Medicare beneficiares in HMO plans-Implications for Medicare costs. J Health Care Finance 2002;28:43-57.